Medical	JJ
treatment	NN
for	IN
pulmonary	JJ
fibrosis	NN
:	:
current	JJ
trends	NNS
,	,
concepts	NNS
,	,
and	CC
prospects	NNS
.	.

A	DT
diagnosis	NN
of	IN
idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
carries	VBZ
a	DT
poor	JJ
prognosis	NN
,	,
with	IN
our	PRP$
currently	RB
available	JJ
therapies	NNS
offering	VBG
little	JJ
clinical	JJ
benefit	NN
.	.

Unfortunately	RB
,	,
recent	JJ
major	JJ
advances	NNS
in	IN
our	PRP$
understanding	NN
of	IN
the	DT
clinical	JJ
and	CC
biologic	JJ
features	NNS
of	IN
this	DT
disease	NN
have	VBP
not	RB
been	VBN
matched	VBN
by	IN
similar	JJ
advances	NNS
in	IN
treatment	NN
.	.

This	DT
is	VBZ
likely	JJ
because	IN
of	IN
the	DT
complex	NN
cascade	NN
of	IN
biologic	JJ
and	CC
pathobiologic	JJ
events	NNS
that	WDT
occurs	VBZ
in	IN
IPF	NN
.	.

The	DT
necessary	JJ
,	,
and	CC
desperately	RB
needed	VBN
,	,
next	IN
generation	NN
of	IN
therapies	NNS
,	,
focused	VBD
on	IN
specific	JJ
molecular	JJ
targets	NNS
thought	VBD
to	TO
play	VB
pivotal	JJ
roles	NNS
in	IN
the	DT
development	NN
and	CC
progression	NN
of	IN
fibrosis	NN
,	,
are	VBP
under	IN
active	JJ
investigation	NN
.	.

